Winning the War on Huntington's Disease - WuXi XPress: for WuXi news and R&D insights
VIP Reception
Michael Hayden Net Worth (2022) | wallmine
Teva Pharmaceutical Industries Ltd. - At the opening of a new scientific research center in the Galilee region of Israel (pictured, left to right): Erez Vigodman, Teva President and CEO; Prof. Ran
New Teva CEO axes R&D chief Hayden in boardroom shakeup -
Troubled Drugmaker Teva to Axe over 4,000 Jobs | Ctech
Senior Advisors copy — Biolojic
Prilenia Therapeutics raises $62.5m, names Michael Hayden CEO - Globes
Teva appoints genetics specialist as its first president of global R&D - PMLiVE
Teva scraps Heptares migraine pact as lead drug nears clinic | Fierce Biotech
Dr. Michael Hayden MBChB , PhD - Chief Executive Officer - Prilenia | LinkedIn
Huntington's drug sprung from Teva's lab moves forward with $62.5M VC backing | S&P Global Market Intelligence
Celebrating Biopharma Innovation: The Top 10 | Reuters Events | Pharma
Axovant poaches Allergan's and Teva's chief medical and science officers - PMLiVE
Incisive Genetics
New Teva CEO shakes up structure and leadership at troubled drugmaker | The Times of Israel
How One of the World's Leading Geneticists Recovered His Family's Stolen Legacy - Tablet Magazine
Michael Hayden, MD, PhD - World Neuroscience Innovation Forum
Michael Hayden, MD PhD | CMHF
How One of the World's Leading Geneticists Recovered His Family's Stolen Legacy - Tablet Magazine
Pridopidine and Michael Hayden makes comeback! – European Huntington Association
Teva R&D Strategy
Michael Hayden - Director at n-Lorem Foundation | The Org
